These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 9761121)
1. Transmembrane 4 superfamily as a prognostic factor in pancreatic cancer. Sho M; Adachi M; Taki T; Hashida H; Konishi T; Huang CL; Ikeda N; Nakajima Y; Kanehiro H; Hisanaga M; Nakano H; Miyake M Int J Cancer; 1998 Oct; 79(5):509-16. PubMed ID: 9761121 [TBL] [Abstract][Full Text] [Related]
2. Correlation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients. Huang CI; Kohno N; Ogawa E; Adachi M; Taki T; Miyake M Am J Pathol; 1998 Sep; 153(3):973-83. PubMed ID: 9736046 [TBL] [Abstract][Full Text] [Related]
3. Novel staging protocol for non-small-cell lung cancers according to MRP-1/CD9 and KAI1/CD82 gene expression. Adachi M; Taki T; Konishi T; Huang CI; Higashiyama M; Miyake M J Clin Oncol; 1998 Apr; 16(4):1397-406. PubMed ID: 9552043 [TBL] [Abstract][Full Text] [Related]
4. Integrin alpha3 expression as a prognostic factor in colon cancer: association with MRP-1/CD9 and KAI1/CD82. Hashida H; Takabayashi A; Tokuhara T; Taki T; Kondo K; Kohno N; Yamaoka Y; Miyake M Int J Cancer; 2002 Feb; 97(4):518-25. PubMed ID: 11802216 [TBL] [Abstract][Full Text] [Related]
5. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer. Adachi M; Taki T; Ieki Y; Huang CL; Higashiyama M; Miyake M Cancer Res; 1996 Apr; 56(8):1751-5. PubMed ID: 8620488 [TBL] [Abstract][Full Text] [Related]
6. Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma. Uchida S; Shimada Y; Watanabe G; Li ZG; Hong T; Miyake M; Imamura M Br J Cancer; 1999 Mar; 79(7-8):1168-73. PubMed ID: 10098753 [TBL] [Abstract][Full Text] [Related]
7. CD82, and CD63 in thyroid cancer. Chen Z; Mustafa T; Trojanowicz B; Brauckhoff M; Gimm O; Schmutzler C; Köhrle J; Holzhausen HJ; Kehlen A; Klonisch T; Finke R; Dralle H; Hoang-Vu C Int J Mol Med; 2004 Oct; 14(4):517-27. PubMed ID: 15375577 [TBL] [Abstract][Full Text] [Related]
8. Clinical significance of CD151 gene expression in non-small cell lung cancer. Tokuhara T; Hasegawa H; Hattori N; Ishida H; Taki T; Tachibana S; Sasaki S; Miyake M Clin Cancer Res; 2001 Dec; 7(12):4109-14. PubMed ID: 11751509 [TBL] [Abstract][Full Text] [Related]
9. Down-regulation of TM4SF is associated with the metastatic potential of gastric carcinoma TM4SF members in gastric carcinoma. Chen Z; Gu S; Trojanowicz B; Liu N; Zhu G; Dralle H; Hoang-Vu C World J Surg Oncol; 2011 Apr; 9():43. PubMed ID: 21521534 [TBL] [Abstract][Full Text] [Related]
11. KAI1/CD82 expression in nonsmall cell lung carcinoma is a novel, favorable prognostic factor: an immunohistochemical analysis. Higashiyama M; Kodama K; Yokouchi H; Takami K; Adachi M; Taki T; Ishiguro S; Nakamori S; Yoshie O; Miyake M Cancer; 1998 Aug; 83(3):466-74. PubMed ID: 9690539 [TBL] [Abstract][Full Text] [Related]
12. Expression of KAI1/CD82 and MRP-1/CD9 in transitional cell carcinoma of bladder. Ai X; Zhang X; Wu Z; Ma X; Ju Z; Wang B; Shi T J Huazhong Univ Sci Technolog Med Sci; 2007 Feb; 27(1):79-82. PubMed ID: 17393117 [TBL] [Abstract][Full Text] [Related]
13. Adenoviral transduction of MRP-1/CD9 and KAI1/CD82 inhibits lymph node metastasis in orthotopic lung cancer model. Takeda T; Hattori N; Tokuhara T; Nishimura Y; Yokoyama M; Miyake M Cancer Res; 2007 Feb; 67(4):1744-9. PubMed ID: 17308116 [TBL] [Abstract][Full Text] [Related]
14. KAI1/CD82 and MRP1/CD9 serve as markers of infiltration, metastasis, and prognosis in laryngeal squamous cell carcinomas. Zhang BH; Liu W; Li L; Lu JG; Sun YN; Jin DJ; Xu XY Asian Pac J Cancer Prev; 2013; 14(6):3521-6. PubMed ID: 23886139 [TBL] [Abstract][Full Text] [Related]
15. A novel molecular staging protocol for non-small cell lung cancer. Miyake M; Adachi M; Huang C; Higashiyama M; Kodama K; Taki T Oncogene; 1999 Apr; 18(14):2397-404. PubMed ID: 10327061 [TBL] [Abstract][Full Text] [Related]
16. [KAI1/CD82 and ME491/CD63 expression in non-small-cell carcinoma of the lung and prognosis]. Adachi M; Taki T; Ieki Y; Ko S; Higashiyama S; Kodama K; Doi S; Miyake M Nihon Kyobu Geka Gakkai Zasshi; 1997 Mar; 45(3):398-401. PubMed ID: 9235357 [No Abstract] [Full Text] [Related]
17. Mapping of the genes for four members of the transmembrane 4 superfamily: mouse Cd9, Cd63, Cd81, and Cd82. Seldin MF; Rochelle JM; Tomlinson MG; Wright MD Immunogenetics; 1995; 42(5):422-5. PubMed ID: 7590978 [No Abstract] [Full Text] [Related]
18. MRP-1/CD9 and KAI1/CD82 expression in normal and various cancer tissues. Huang C; Taki T; Adachi M; Yagita M; Sawada S; Takabayashi A; Inufusa H; Yoshie O; Miyake M Int J Oncol; 1997 Nov; 11(5):1045-51. PubMed ID: 21528303 [TBL] [Abstract][Full Text] [Related]
19. KAI1/CD82 expression as a prognosic factor in sporadic colorectal cancer. Muneyuki T; Watanabe M; Yamanaka M; Shiraishi T; Isaji S Anticancer Res; 2001; 21(5):3581-7. PubMed ID: 11848527 [TBL] [Abstract][Full Text] [Related]
20. Mutation and expression of the metastasis suppressor gene KAI1 in esophageal squamous cell carcinoma. Miyazaki T; Kato H; Shitara Y; Yoshikawa M; Tajima K; Masuda N; Shouji H; Tsukada K; Nakajima T; Kuwano H Cancer; 2000 Sep; 89(5):955-62. PubMed ID: 10964324 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]